Are you Dr. Brunhoeber?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 25 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Midland Ave
Port Chester, NY 10573Phone+1 800-942-3376Fax+1 914-934-9819- Is this information wrong?
Summary
- Dr. Patrick Brunhoeber, MD is a board certified pathologist in Port Chester, New York. He is currently licensed to practice medicine in New York, Connecticut, and Arizona.
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Molecular Genetic Pathology, 2009 - 2010
- SUNY Downstate Health Sciences UniversityFellowship, Dermatopathology, 2007 - 2008
- University of Arizona College of Medicine-TucsonResidency, Pathology-Anatomic and Clinical, 2003 - 2007
- University of Arizona College of MedicineClass of 2003
Certifications & Licensure
- AZ State Medical License 2006 - 2025
- NY State Medical License 2008 - 2010
- CT State Medical License 2009 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 23 citationsImmunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of...Katerina Dvorak, Amanda Higgins, John Palting, Michael Cohen, Patrick Brunhoeber> ;Pathology Oncology Research. 2019 Jan 1
- 23 citationsPrognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studiesUlrich-Peter Rohr, Pia Herrmann, Katharina Ilm, Hai Zhang, Sabine Lohmann, Astrid Reiser, Andrea Muranyi, Janice Smith, Susen Burock, Marc Osterland, Katherine Leith, ...> ;Annals of Oncology. 2017 Aug 1
- 23 citationsGirdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair Proficient Stage II Colon CancerPradipta Ghosh, Jeanne Tie, Andrea Muranyi, Shalini Singh, Patrick Brunhoeber, Katherine Leith, Rebecca Bowermaster, Zhiming Liao, Yifei Zhu, Bonnie LaFleur, Ben Tran,...> ;Clinical Cancer Research. 2016 Mar 30
- Join now to see all